ArticleOphthalmology and therapy2024

Safety and Efficacy of Multiple Escalating Doses of RC28-E for Neovascular Age-Related Macular Degeneration: A Phase 1b Trial.

Yingyi Lu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.